The best CBD for insomnia: CBD oil and capsules for sleep

September 23, 2021
10:22 am

Justice News Flash Report

The best CBD for insomnia: CBD oil and capsules for sleep

[ad_1]

¹Irwin, MR, Olmstead, R., & Carroll, JE (2016). Sleep disorders, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry, 80(1), 40–52. https://doi.org/10.1016/j.biopsych.2015.05.014

²Cooper CB, Newfield electric car, Dolezar BA, Wait

Sleep deprivation and obesity in adults: a brief narrative review

BMJ Open Sports and Sports Medicine 2018;4:e000392. road: 10.1136/bmjsem-2018-000392

³Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S. and Corsi, L. (2018). marijuana L. and non-psychoactive cannabinoids: their chemical effects and effects on oxidative stress, inflammation and cancer. International Biomedical Research, 2018, 1691428. https://doi.org/10.1155/2018/1691428

⁴VanDolah, HJ, Bauer, BA, & Mauck, KF (2019). Clinician’s Guide for Cannabidiol and Cannabis Oil. Mayo Clinic Procedure, 94(9), 1840-1851. https://doi.org/10.1016/j.mayocp.2019.01.003

⁵Hui-Chen Lu, Ken Mackie, A systematic review of endocannabinoids, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2020, ISSN 2451-9022, https://doi.org/10.1016/j.bpsc.2020.07 .016.

⁶Shannon, S., Lewis, N., Lee, H. and Hughes, S. (2019). Anxiety and cannabidiol in sleep: a large case series. Permanent magazine, twenty three, 18–041. https://doi.org/10.7812/TPP/18-041

⁷Surayev A sort of, Glenstein RR, Marshall National Service, Wait Cannabidiol (CBD) and ?⁹-Tetrahydrocannabinol (THC) in the treatment of chronic insomnia (“CANSLEEP” trial): randomized, placebo-controlled, double-blind, proof-of-concept trial protocol BMJ Open 2020;10:e034421. road: 10.1136/bmjopen-2019-034421

⁸Bachhuber M, Arnsten JH, Wurm G. Adult-use pharmacies use marijuana to relieve pain and promote sleep. Journal of Psychotropic Drugs. October 20, 2019; 51(5):400-4. https://doi.org/10.1080/02791072.2019.1626953

⁹De Almeida DL, Devi LA. The diversity of CBD molecular targets and signaling pathways. Pharmacological research and prospects. December 2020; 8(6): e00682. https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.682

¹⁰dos Santos RG, Halak JEC, Crippa JAS (2021) Neuropharmacological effects of major phytocannabinoids: a narrative review. In: Murillo-Rodriguez E., Pandi-Perumal SR, Monti JM (editors) Cannabinoids and neuropsychiatric disorders. Advances in Experimental Medicine and Biology, Volume 1264. Springer, Cham. https://doi.org/10.1007/978-3-030-57369-0_3

¹¹Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. The brain activity of anandamide: a beneficial happiness? . Pharmacology News. March 2019; 40 (3): 309-23. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6460372/

[ad_2]

Source link